Counselors in Prospect, CT Accepting Medicare

5 Counselors found. Showing 1 - 5

Caitlin Sullivan, MS Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 51 Smoke Rise Cir, Prospect, CT 06712 Phone: 203-695-5762

Ms. Sharon Anita Anthony, MSW Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 60 Waterbury Rd Ste D, Prospect, CT 06712 Phone: 203-527-9551    Fax: 203-758-7636

Mr. Stephen Ciucci, L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2 Summit Rd, Suite L, Prospect, CT 06712 Phone: 203-758-3522    Fax: 203-758-3522

Jonathan Trapp Counselor Medicare: Not Enrolled in Medicare Practice Location: 18 Summit Rd, Prospect, CT 06712 Phone: 203-233-5349

Ms. Laurie L Gambardella, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 11 Tamarack Ct, Prospect, CT 06712 Phone: 336-508-1298

News Archive

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.

Bioethicists call for oversight of poorly regulated, consumer-grade neurotechnology products

The marketing of direct-to-consumer "neurotechnologies" can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or "read" one's emotional state. However, many of these increasingly popular products aren't fully supported by science and have little to no regulatory oversight, which poses potential health risks to the public.

NeoStem to present VSEL Technology for Battlefield Wounds treatment at USU-HJF Symposium

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, today announced that the Company will be presenting its Autologous Adult Stem Cell VSEL Technology for the Treatment of Battlefield Wounds at The USU-HJF Military Medicine Symposium in Washington DC, September 23rd, 2010.

Yale researchers monitor growth of laboratory-engineered blood vessels after implantation

Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other tissues engineered from a patient's own biological material, are taking hold and working as expected.

CompPartners, Emerald Claims Management partner to provide intake and triage services to injured employees

CompPartners has partnered with Emerald Claims Management to provide intake and triage services to injured employees. The program expedites the delivery of medical services to claimants and reduces lost-time claims.

Read more Medical News

› Verified 2 days ago